6515--Intent to sole source NEXTSEQ 2000 SEQUENCING SYSTEM

Status
Inactive
Published Date
October 10th, 2023
Response Deadline
July 27th, 2023
Notice Type
Special Notice
Solicitation No.
36C24223Q0975

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Summary

Title: Intent to Sole Source NextSeq 2000 Sequencing System Department: Veterans Affairs, Department of Procurement Target: NextSeq 2000 Sequencing System instrument Summary: The Veterans Affairs, Department of intends to sole source a purchase order for the NextSeq 2000 Sequencing System instrument through Illumina Inc. This procurement is for the James J. Peters VAMC in Bronx, NY, specifically for COVID sequencing in the Research department. The NextSeq 2000 Sequencing System is an integrated system used for automated DNA clonal cluster generation, sequencing, and analysis. It is essential for the VAMC to sequence COVID and is believed to be the only suitable candidate. The system has the capability to run multiple samples at a great sequencing depth with a significantly lower cost. It is also compatible with FDA EUA approved COVIDseq test kit for detecting SARS-CoV-2. The system's high quality and accuracy in sequencing and analysis of variants make it especially useful in COVID research. The procurement includes the instrument, embedded touchscreen monitor, control software, DRAGEN Bio-IT secondary analysis pipelines, installation, training, and 12 months warranty. The NextSeq 2000 system is currently being used successfully at other VA sites. This notice of intent is not a request for competitive quotes, and no solicitation will be made available. Responses will be considered for future procurements.

Description

NOTICE OF INTENT TO SOLE SOURCE Department of Veterans Affairs (VA) Network Contracting Office 2 (NCO 2) hereby gives notice of the Government s intent to sole source a purchase order for NextSeq 2000 Sequencing System instrument, through Illumina Inc., for the James J. Peters VAMC, 130 West Kingsbridge Road, Bronx NY 10468. The Research department at the James J. Peters VAMC is requesting a NextSeq 2000 instrument to run COVID sequencing. Illumina NexSeq 2000 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and secondary analysis which is essential for the V to sequence COVISD. It is the Government s belief that the proposed candidate is the only one that can provide James J. Peters NexSeq 2000 instrument that is needed. The applicable North American Industry Classification System (NAICS) code is 334516 (Analytical laboratory Instrument manufacturing) with a small business size standard of 1000 Employees and the Federal Supply Code (FSC) is 6515 (Medical, surgical Instruments, Equipment and Supplies). REQUIREMENTS AND DELIVERABLES Next generation sequencing (NGS) is answering complex scientific questions with genomics. The NextSeq 2000 (Illumina) has the capability to run multiple samples at a great sequencing depth with a significantly lower cost. This sequencer is a flexible work platform that has the capability to sequence our desired COVID targets as well as support future research applications in the areas of virology, oncology and pathology. The NextSeq 2000 system includes embedded touchscreen monitor and on-instrument computer, control software, hardware accelerated DRAGEN Bio-IT secondary analysis pipelines, installation and training, and 12 months warranty (including parts and labor). The Illumina system is especially useful in COVID research due to its compatibility with FDA EUA approved COVIDseq test kit for detecting the SARS-CoV-2. COVID variants are spreading rapidly and with the NextSeq 2000 it provides high quality and accuracy in sequencing for sequencing read and analysis of variants. This system is currently being used at other VA sites with success. This will allow the James J. Peters VA to validate other findings and compare results with other VAs nationwide. Brand name specifications: Next Seq2000 consists of: Instrument dimensions: Height 60 cm (23.6 in) Width 60 cm (23.6 in) Depth 65 cm (25.6 in) Weight 141 kg (310.9 lb) On instrument computer Control software Hardware accelerated DRAGEN Bio-IT secondary analysis pipelines Installation and training 12 months warranty (including parts and labor) This notice of intent is not a request for competitive quotes and no solicitation will be made available. Any response received NLT July 27, 2023, at 10AM will be considered for the purpose of determining sources for future procurements Tina.Cavalieri@va.gov. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. A determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government. No telephone inquiries will be accepted. THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS. This will be the only notice of the Government s intent to solicit, negotiate, and award to one source to satisfy this requirement.

Contact Information

PrimaryTina M CavalieriTina.Cavalieri@va.gov
(914) 737-4400 x2065
tina.cavalieri@va.gov
Attachments
25 KB